ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664874 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664874; 2) Community: the network communities that were significantly associated with the response to NSC 664874; 3) Molecule: the relationships between components within communities and NSC 664874; 4) MDR: the compounds that were significantly associated with the NSC 664874.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0105972823829604 0.21593938
NSC 72961 8-Azadenosine 0.0105972823829604 0.21743128
NSC 740 Methotrexate 0.0105972823829604 0.39982037
NSC 743528 Null 0.0105972823829604 0.16045136
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0105972823829604 0.38235819
NSC 153353 L-Alanosine 0.0119221520283057 0.088953896
NSC 30656 p,p'-Bis(dimethylamino)thiobenzophenone 0.0119221520283057 0.2993917
NSC 628301 Null 0.0119221520283057 0.42106579
NSC 629155 Null 0.0119221520283057 0.47752794
NSC 665713 Null 0.0119221520283057 0.14841765
Total:98  Current:31    [First] [Prev] [Next] [Last]